Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioClinica Inks $30 Million in eClinical Contracts

Published: Saturday, March 29, 2014
Last Updated: Saturday, March 29, 2014
Bookmark and Share
Multi-year signings for enterprise-wide technology and support.

BioClinica®, Inc. has announced that it has recently penned $30 million in multi-year contract renewals with two major pharmaceutical companies.

Collectively these engagements encompass cloud-based technologies and professional services and training across BioClinica's full eClinical product suite: OnPoint CTMS, Express EDC, Trident IRT, and clinical supplies Optimizer.

Under the contracts BioClinica will support several hundred clinical studies annually through 2017. "Large back-to-back awards like this demonstrate that BioClinica lives up to the high expectations of top tier pharma," BioClinica's President of eClinical Solutions Peter Benton said. "BioClinica technologies accommodate the high volume of studies conducted by large life science companies and enable sponsors to drive their research forward."

The contracts extend partnering arrangements that originated a decade ago. Since then, BioClinica has supported the two organizations in clinical trials across thousands of investigative sites worldwide.

BioClinica technologies create efficiencies that compress the clinical investigation timeline. "In our experience with one of these customers we have reduced study start-up time to two weeks on most of their trials and have cut close-out time to just one week," according to Benton. "Employing standards and electronic forms libraries also brings speed and efficiency, which becomes especially apparent to sponsors like this who are running high volume studies."

In the first agreement, BioClinica will provide resources and subject matter expertise in clinical supply chain distribution systems and processes that extend to several thousand investigators using Interactive Response Technology (IRT) worldwide.

In the second agreement, BioClinica's easy-to-use OnPoint CTMS and Express EDC technologies will provide the foundation for their clinical operations.

Data management, study design, and related professional services that support clinical studies globally will also be provided.

Enterprise-wide implementation of cloud-based technologies is currently underway with BioClinica employees contracted to be embedded within each organization, augmenting the pharmaceutical companies' internal resources.

BioClinica will hold its Global User Conference on May 5-7 in Philadelphia, Pennsylvania where the latest features of its full eClinical product lineup will be demonstrated. Customers may register online for the 2014 BioClinica User Conference.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

BioClinica Launches New eClinical CRO Partner Alliance Program
Access to eClinical knowledge, best practices and financial benefits drive CRO success.
Saturday, October 24, 2015
BioClinica Acquires Synowledge
Adds capabilities in pharmacovigilance and regulatory technology, data analysis and business process management.
Friday, September 25, 2015
BioClinica Expands Operational Capabilities, Opens New European Offices
Combined space of 1,400 square meters to support clinical trial services.
Thursday, July 02, 2015
BioClinica and Kinapse Partner to Accelerate RBM Implementation
Bolsters adoption of compass intelligent monitoring solution.
Thursday, May 28, 2015
BioClinica Names Mukhtar Ahmed as eClinical President
Technology and industry leader to head eClinical business unit.
Friday, April 24, 2015
BioClinica Opens Research Triangle Park Office
Sponsors and CRO strategic partners drive RTP expansion.
Friday, March 27, 2015
BioClinica Grows eClinical Results in Europe
Expands presence to meet demand for EDC, CTMS and IRT Technologies.
Friday, February 07, 2014
BioClinica and Rutgers University Announce Research Project Results
Scientific Partnership Aims to Expand Automation of Clinical Trial Image Data Analysis
Saturday, November 23, 2013
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!